SCHEMBL3961022

SCHEMBL3961022

C=CCc1ccc2c(c1)-c1cc(CC=C)ccc1C2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 8/20 0.57
GABRB2 P47870 8/20 0.57
CNR2 P34972 5/20 0.57
ALDH1A1 P00352 4/20 0.57
MAPT P10636 3/20 0.57
MEN1 O00255 2/20 0.57
GAA P10253 2/20 0.57
CNR1 P21554 2/20 0.57
KMT2A Q03164 2/20 0.57
PPARG P37231 2/20 0.57
PPARD Q03181 2/20 0.57
KDM4E B2RXH2 1/20 0.57
ALDH2 P05091 1/20 0.57
AKR1B1 P15121 1/20 0.57
HPGD P15428 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
XDH P47989 1/20 0.48
TNKS O95271 2/20 0.47
PARP1 P09874 1/20 0.47
CYP3A4 P08684 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7153161 0.94 ALDH1A1 (0.52) GABRA1GABRB2CNR2ALDH1A1MAPT
SCHEMBL10374502 0.83 ALDH1A1 (0.51) GABRA1GABRB2CNR2ALDH1A1MAPT
SCHEMBL23527433 0.81 ALDH1A1 (0.46) GABRA1GABRB2CNR2ALDH1A1MAPT
SCHEMBL23527421 0.78 MAOA (0.55) GABRA1GABRB2CNR2ALDH1A1MAPT
SCHEMBL6273719 0.76 GABRA1 (0.49) GABRA1GABRB2CNR2ALDH1A1MAPT
SCHEMBL10494619 0.75 XDH (0.48) GABRA1GABRB2CNR2ALDH1A1MAPT
SCHEMBL1245219 0.74 GABRA1 (0.61) GABRA1GABRB2CNR2ALDH1A1MAPT
SCHEMBL24650531 0.73 XDH (0.47) GABRA1GABRB2CNR2ALDH1A1MAPT
SCHEMBL2732487 0.73 MAOA (0.48) GABRA1GABRB2CNR2ALDH1A1MAPT
Magnolol SCHEMBL132477 0.72 GABRA1 (1.00) GABRA1GABRB2CNR2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7094938-B1 Process for the preparation of substituted fluorenes FINA TECHNOLOGY, INC. (US) 2006-08-22 US claimed
CN-101180249-B Fluorene derivative, transition metal compound, catalyst for olefin polymerization, and process for producing olefin polymer MITSU CHEMICALS INC 2012-06-20 CN disclosed
US-7605294-B2 Process for the preparation of substituted fluorenes FINA TECHNOLOGY, INC. (US) 2009-10-20 US disclosed
US-20090076315-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED FLUORENES FINA TECHNOLOGY, INC. (US) 2009-03-19 US disclosed
US-7473813-B2 Process for the preparation of substituted fluorenes FINA TECHNOLOGY, INC. (US) 2009-01-06 US disclosed
CN-101180249-A Fluorene derivative, transition metal compound, catalyst for olefin polymerization, and process for producing olefin polymer MITSUI CHEMICALS INC (JP) 2008-05-14 CN disclosed
US-20070015946-A1 Process for the preparation of substituted fluorenes MARIN VLADIMIR 2007-01-18 US disclosed
US-7094938-B1 Process for the preparation of substituted fluorenes FINA TECHNOLOGY, INC. (US) 2006-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015946-A1 Process for the preparation of substituted fluorenes TFDP2, ZKSCAN2, MDM4 GABRA1 3743/4885GABRB2 3889/4885CNR2 1898/4885
US-20090076315-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED FLUORENES TFDP2, ZKSCAN2, MDM4 GABRA1 3743/4885GABRB2 3889/4885CNR2 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.